Article Information
History
- December 4, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bachisio Ziccheddu1,*,
- Claudia Giannotta2,*,
- Mattia D’Agostino3,*,
- Giuseppe Bertuglia3,
- Elona Saraci3,
- Stefania Oliva3,
- Elisa Genuardi3,
- Marios Papadimitriou1,
- Benjamin Diamond1,
- Paolo Corradini4,
- David Coffey1,
- Ola Landgren1,
- Niccolò Bolli5,6,
- Benedetto Bruno3,
- Mario Boccadoro3,
- Massimo Massaia2,7,#,
- Francesco Maura1,#^ and
- Alessandra Larocca3,#
- 1Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA
- 2Laboratory of Blood Tumor Immunology, Molecular Biotechnology Center “Guido Tarone”, Department of Molecular Biotechnology and Health Sciences, Università di Torino, Torino, Italy
- 3Myeloma Unit, Division of Hematology, Università di Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
- 4Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 5Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- 6Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy
- 7SC Ematologia, AO S. Croce e Carle, Cuneo, Italy
- ↵^CORRESPONDING AUTHORS
Francesco Maura, MD Myeloma Division, Sylvester Comprehensive Cancer Center University of Miami 1120NW 14th Street, Clinical Research Building Miami, FL 33136 Phone (305)243-7687 E-mail: fxm557{at}med.miami.edu
↵* Contributed equally
Posted December 04, 2023.
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
